---
title: "Altamira Therapeutics (OTCQB: CYTOF) reports 2024 financial results, focuses on expanding RNA delivery technology."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/238284873.md"
description: "Bermuda-based Altamira Therapeutics Ltd. (OTCQB: CYTOF) announced its business update and disclosed its financial performance for the full year of 2024. Altamira focuses on developing and marketing RNA delivery technology for non-liver targets."
datetime: "2025-04-30T12:22:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/238284873.md)
  - [en](https://longbridge.com/en/news/238284873.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/238284873.md)
generator: "portal-rs"
---

# Altamira Therapeutics (OTCQB: CYTOF) reports 2024 financial results, focuses on expanding RNA delivery technology.

Bermuda-based Altamira Therapeutics Ltd. (OTCQB: CYTOF) announced its business update and disclosed its financial performance for the full year of 2024. Altamira focuses on developing and marketing RNA delivery technology for non-liver targets.

### Related Stocks

- [CYTOF.US](https://longbridge.com/en/quote/CYTOF.US.md)

## Related News & Research

- [Shipping Route Chaos Is Repricing Global Logistics Stocks](https://longbridge.com/en/news/298564081.md)
- [Oriola expands Nordic distribution partnership with Takeda in Finland](https://longbridge.com/en/news/298705251.md)
- [3 Stocks Tied To ESG Reporting Demand As Climate Rules Tighten](https://longbridge.com/en/news/298485236.md)
- [Orkla trims ORK89 bond holdings to boost market float](https://longbridge.com/en/news/298495215.md)
- [Cibus accepts SEK 386 million in green notes tender offer at 101.25%](https://longbridge.com/en/news/298591072.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**